This Study Seeks to Prevent Cancer By Targeting Genetic Risk For Ovarian Cancer

This Study Seeks to Prevent Cancer By Targeting Genetic Risk For Ovarian Cancer

Researchers in gynecologic oncology have begun testing a promising surgery for premenopausal women at high genetic risk for ovarian cancer that avoids early menopause and may prevent these malignancies from developing. Studies have shown that most ovarian cancers actually begin to grow from cancer cells that developed in the fallopian tubes. This trial is testing … Read more

This Scientist Focuses On How Cells Record Trauma

This Scientist Focuses On How Cells Record Trauma

Barbara Engelhardt, PhD, builds machine-learning models and statistical tools to make use of data (scientific experiments, longitudinal studies, clinical trials, and hospital records) and find ways to better understand, and even prevent, disease. She is now joining Gladstone Institutes as a senior investigator. Engelhardt is also a full professor at Princeton University, on leave this … Read more

NIH To Fund $185 Million For Research Into Human Genome Functions

NIH To Fund $185 Million For Research Into Human Genome Functions

The National Institutes of Health (NIH) is providing approximately $185 million over five years to the Impact of Genomic Variation on Function (IGVF) consortium, initiated and funded by NIH’s National Human Genome Research Institute (NHGRI). NHGRI will fund 25 awards across 30 U.S. research sites. IGVF consortium investigators will work to understand how genomic variation … Read more

In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks

In Conversation: Matthew McKnight, Chief Commercial Officer, Ginkgo Bioworks

Synthetic.com’s publisher and editor, Simons Chase, interviews Matthew McKnight. Matt is the Chief Commercial Officer of Ginkgo Bioworks where he also leads the company’s biosecurity platform, Concentric by Ginkgo. Prior to Ginkgo, Matt spent 7 years as an investor at IndUS Growth Partners and was the President and COO of Decision Resources Group. He has … Read more

Categories IPO

Chinese Firm’s Collection Of Global Prenatal DNA Could Fuel Ethno-Nationalist Aims

Chinese Firm’s Collection Of Global Prenatal DNA Could Fuel Ethno-Nationalist Aims

BGI Group, a Chinese gene company, is collecting genetic data through prenatal tests from women in more than 50 countries for research on the traits of populations, raising concern that such a large DNA database could give China a technological advantage and the strategic edge to dominate global pharmaceuticals, according to a recent news report. … Read more

Genome Medical Raises C Round Led By Casdin, Acquires Telehealth Genetic Counseling Company

Genome Medical Raises C Round Led By Casdin, Acquires Telehealth Genetic Counseling Company

Genome Medical, a genomic care delivery company, today announced that it will acquire GeneMatters, a telehealth genetic counseling and software solutions company.  The company also announced the closing of a $60 million Series C financing to accelerate commercial traction and advance its mission to advance genomic medicine.   “The addition of GeneMatters, along with our … Read more